Lv12
40 积分 2021-07-04 加入
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
1天前
已完结
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study
1天前
已完结
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study
14天前
已完结
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study
14天前
已完结
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial
15天前
已完结
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
1个月前
已完结
Pediatric AML: state of the Art and Future Directions
7个月前
已完结
How I Treat on Infant Acute Lymphoblastic Leukemia
7个月前
已完结
Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia that is not in remission
4年前
已关闭
Epidemiological Study of Mutiple Myeloma In Spain: Efectiveness and Survival Analysis
4年前
已完结
皖公网安备34019202002308
